FRACTYL HEALTH, INC. - 8-K Filing
Fractyl Health reports Q3 2026 results, announces 45% workforce reduction, and targets FDA De Novo submission for Revita in late Q4 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)